The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.
Newleaf Brands is an innovative Cannabidiol (“CBD”) lifestyle Company. Through the Company’s wholly owned subsidiaries We are Kured and Drink Fresh Water, the Company’s main business activities encompass the development, marketing and distribution of CBD products (including vaporizer pens and beverages) throughout the United States and internationally. In addition, Newleaf Brands has extensive retail and cultivation land investments in Oregon.
The Company, through its subsidiary, intends to focus on its vertically integrated "seed-to-sale" operations in the City of Coalinga, California. The Company holds Type R (Nursery Cultivation), Type 3A (Indoor Cultivation), Type 7 (Volatile Extraction) and Type 12 (Distribution) Conditional Use Permits that will enable it to produce, process, distribute and sell premium cannabis and cannabinoid infused products in the State of California.
Nextleaf Solutions Ltd. ("OILS") is the first public company to be issued a U.S patent for industrial-scale extraction and purification of cannabinoids. OILS has developed a portfolio of multiple issued and pending patents pertaining to the company’s unique, industrial-scale process of producing purified cannabinoid distillate, a tasteless, odourless cannabis concentrate best suited for infusing premium value-added products. Upon cannabis concentrates becoming legal across Canada on October 17, 2019, OILS plans to commercialize its intellectual property portfolio through B2B processing services and the supply of cannabis oils and concentrates to qualified Canadian and international partners. For more information, visit www.NextleafSolutions.com
NHS Industries Ltd. is an agri-services company aimed at providing turnkey services to makers, bakers and growers. NHS is in the process of building out a commercial commissary kitchen that will be available to on site growers as well as local makers, bakers and growers producing small batch artisanal food products.
North Bud Farms Inc., through its wholly owned subsidiary GrowPros MMP Inc., is pursuing a licence under The Cannabis Act. North Bud Farms Inc. is constructing a state-of-the-art purpose-built cannabis production facility located on 95 acres of Agricultural Land in Low, Quebec. North Bud Farms Inc. will be focused on Pharmaceutical and Food Grade cannabinoid production in preparation for the legalization of edibles and ingestible products scheduled for October 2019.
Nutritional High is primarily focused on developing, acquiring and designing products and brands in the marijuana-infused edible products and oil extracts sectors for medical and adult recreational use. The Company works exclusively in U.S. states where such activity is permitted and regulated by state law, through entities which hold a valid license to produce marijuana-infused edible products and to distribute and dispense marijuana products.
Orchid Essentials is an award-winning cannabis brand with THC and CBD product lines currently sold in 275+ dispensaries across California and Oregon.
The Issuer’s mission is to create the highest standards in the cannabis industry and be committed to safety, efficacy, and quality. The Issuer uses natural terpenes and ensures that its materials are thoroughly screened for pesticides, solvents, heavy metals, and bacteria while also ensuring high-potency cannabinoid and terpene levels.
Orion Nutraceuticals Inc. produces and develops innovative products with key strategic partners in the cannabis life science industry. In conjunction with its professional sports strategic alliances, the company intends to advance research and development in the plant science sector, deliver science-based products and services, and market CBD therapies to the mainstream with proprietary brands and products.
Ortho RTi is an emerging Orthopaedic and Sports Medicine biologics company dedicated to the development of novel therapeutic soft tissue repair technologies to dramatically improve the success rate of sports medicine surgeries. Our proprietary biopolymer has been specifically designed to increase the healing rates of sports related injuries to tendons, meniscus, ligaments and cartilage. The polymer can be directly placed into the site of injury by a surgeon during a routine operative procedure without significantly extending the time of the surgery and without further intervention. Considering the significant bioactivity and residency of our proprietary biopolymer, Ortho RTi continues to assess its potential for therapeutic uses outside of the soft tissue repair.